Creator Content Steals the Spotlight at TV Upfronts as Media Giants Court Younger Audiences Rush RUSHA Q1 2026 Earnings 077 EPS Surges Past 071 Estimates First FCNCN Q1 2026 Beat Revenue NA EPS Exceeds by Significant SBI Reduces Bulk Term Deposit Rates Across Four Tenors by 25 Basis Points SpaceX Supply Chain Stocks Graded Ahead of Potential IPO Pakistan to Deploy Paramilitary Force to Guard CopperGold Belt FICO Mounts Defense Against Rising VantageScore Competition SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms Custard Apple Cultivation Hardy Plant Fragile Fruit Poses Export Challenges Peter Schiff Renews Criticism of MicroStrategy Over Rising Leverage Risks STWD Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Uptick INVA Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain SDST Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase CLW Q1 2026 Earnings EPS Beats Estimates Despite Negative Earnings Stock Edges Lower QRHC Q1 2026 Earnings EPS Miss Highlights Operational Headwinds and Cost Pressures SRFM Q1 2026 Earnings EPS Surprise Beats Estimates Amid PreRevenue Operations ASBA Holds Steady at 2475 Subordinated Note Trading in Tight Range DarioHealth DRIO Slips Over 4 as Selling Pressure Tests Key Support Levels Adamas Trust Senior Notes ADAMO Hold Steady Near 2528 Amid Low Volatility Valhi Inc VHI Slips 343 as Shares Approach Critical Support Full House Resorts FLL Rises 204 as Stock Nears Key Resistance Level TikTok Goes Dark in the US Trump Signals Potential Intervention Waymo Expands Robotaxi Fleet with Ojai Vehicles Targets Lower Expansion Costs AI Infrastructure and Energy Stocks Outperform Nvidia The New Frontier of Artificial Intelligence Investment Adani Enterprises Among Eight Stocks Hitting 52Week Highs Rallying Up to 30 in a Month Why US 10Year Bond Yields Serve as a Critical Market Barometer for Global Investors Zen Technologies Surges Over 7 on Smart Border Suite Launch Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues MBX Biosciences MBX Surges Over 3 as Stock Approaches Key Resistance Level